期刊文献+

Ⅱ型糖尿病与肠道菌群及益生菌的相关性研究进展 被引量:7

Research progress on relationship between type 2 diabetes, gut microbiota and probiotics
下载PDF
导出
摘要 Ⅱ型糖尿病是一种常见的慢性代谢性疾病,其发病机制十分复杂,其中肠道菌群在其发病早期和加重过程中都起着重要的作用。益生菌作为调节肠道菌群的有效手段,可以通过改善肠道通透性、调节血脂、增强机体免疫力等多种机制对II型糖尿病起到预防和改善作用。现就近年来肠道菌群和2型糖尿病的相关性以及益生菌的作用研究进展作一综述。 Type 2 diabetes is a common chronic metabolic diseases with complex pathogenesis, Gut microbiota plays an important role in the early onset and deterioration of the diabetes.As an effective means of regulating gut microbiota, probiotics are living organisms that are primari- ly used in the prevention and alleviation of type 2 diabetes by improving the intestinal permeability, regulating the serum lipids, enhancing im- munity and other mechanisms. In this review,we discuss the research advance about links between the gut microbiota and type 2 diabetes as well as the role of probiotics in recent years.
出处 《中国乳品工业》 CAS 北大核心 2013年第8期48-51,共4页 China Dairy Industry
基金 内蒙古自治区科技计划项目(209-202060)
关键词 II型糖尿病 肠道菌群 益生菌 type II diabetes gut microbiota probiotics
  • 相关文献

参考文献38

  • 1TUTTLE K R, ANDERSON P W. A Novel Potential Therapy for Diabetic Nephropathy and Vascular Complications: Protein Kinase C Beta Inhibition[J]. AmJ. Kidney Dis., 2003,42(3):456-465.
  • 2GILOVEIL J K, ILATHI S S, VATS V. Amelioration of Experimental Diabetic Neuropathy and Gastropathy in Rats Following oral Adminis- tration of Plant (Eugenia Jambolana, Mucuna Pruriens and Tinospora Cordifolia) Extracts[J]. Indian J Exp Biol, 2002,40 (3):273-276.
  • 3GROVER J K, RATHI S S, VATS V. Amelioration of Experimental Diabetic Neuropathy and Gastropathy in Rats Following oral Adminis- tration of Plant (Eugenia Jambolana, Mucuna Pruriens and Tinospora Cordifolia) Extracts[J]. Indian J Exp Biol, 2002,40 (3):273-276.
  • 4MUKHOPADHYAY P, BASU A K. Management of Diabetic Gastro- paresis[J]. J Indian Med Assoc,2005,103(3):184 - 186.
  • 5QIN J, LI R, RAES J. A Human Gut Microbial Gene Catalogue Estab- lished by Metagenomic Sequencing[J]. Nature, 2010,464(7285):59-65.
  • 6FULLER R. Probiotic in Man and Animals [J]. J Appl Bacteriol, 1998,365 - 378.
  • 7TILG H, KASER A. Gut Microbiome,Obesity,and Metabolic Dys- function[J]. J Clin Invest, 2011,121 (6):2126-2132.
  • 8TURNBAUGH PJ, LEY RE, MAHOWALD MA, et al. An Obesity- associated Gut Microbiome with Increased Capacity for Energy Harvest [J]. Nature, 2006,444 (7122):1027-1031.
  • 9JIA W, LI H, ZHAO L, et al. Gut Microbiota: a Potential New Terri- tory for Drug Targeting[J]. Nat Rev Drug Discov, 2008,7(2):123-129.
  • 10CANI PD, OSTO M, GEUR.TS L, et al. Involvement of Gut Micro-biota in the Development of Low-grade Inflammation and Type 2 Di- abetes Associated with Obesity[J]. Gut Microbes, 2012,3(4):279-288.

同被引文献86

引证文献7

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部